{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-046167","form_type":"8-K","ticker":"ACXP","cik":"0001736243","company_name":"Acurx Pharmaceuticals, Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.515864+00:00","generated_at":"2026-05-22T04:57:52.700106+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Acurx Pharmaceuticals secures up to $12M equity line from Lincoln Park Capital","bullets":["Lincoln Park committed to purchase up to $12M in common stock over 24 months.","Regular purchases up to 60k shares/day (90k if stock ≥$2, 120k if ≥$3).","Purchase price set at 97% of lowest of day's low or avg of three lowest closes in prior 10 days.","Company issued 899,258 commitment shares to Lincoln Park as consideration.","Proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-046167","json":"https://secwatch.observer/filing/0001104659-25-046167.json","markdown":"https://secwatch.observer/filing/0001104659-25-046167.md","text":"https://secwatch.observer/filing/0001104659-25-046167.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925046167/0001104659-25-046167-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1736243/000110465925046167/tm2514277d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T04:57:52.700106+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}